CryoPort, Inc. Common Stock (CYRX) Stock Price

CYRXStock

$16.84+57.24%52W

Market Cap$852.93M

P/E10.89x

PEG Ratio62.13

Div yield—

Beta1.88

CYRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)59.34%

Price vs S&P 500 (4W)-3.10%

PEG Ratio62.13

VGM Score59.09

P/E Ratio (Annual)10.89x

Book Value / Share (Quarterly)$9.69

P/TBV (Annual)1.32x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-9.45%

Cash Flow / Share (Quarterly)$-0.42

Price vs S&P 500 (YTD)63.49%

Gross Margin (TTM)47.08%

Net Profit Margin (TTM)-20.05%

EPS (TTM)$-0.75

10-Day Avg Trading Volume0.82M

EPS Excl Extra (TTM)$-0.75

Revenue Growth (5Y)17.49%

EPS (Annual)$1.56

ROI (Annual)11.35%

Gross Margin (Annual)47.14%

Net Profit Margin (5Y Avg)-37.60%

Cash / Share (Quarterly)$7.83

P/E Basic Excl Extra (TTM)10.02x

Revenue Growth QoQ (YoY)7.74%

P/E Normalized (Annual)10.89x

ROA (Last FY)10.24%

Revenue Growth TTM (YoY)-8.01%

EBITD / Share (TTM)$-0.28

ROE (5Y Avg)-16.59%

Operating Margin (TTM)-21.25%

Cash Flow / Share (Annual)$-0.56

P/B Ratio1.74x

P/B Ratio (Quarterly)1.61x

Net Income / Employee (Annual)$114,500

EV / Revenue (TTM)4.14x

Net Interest Coverage (TTM)-194.57x

ROA (TTM)-4.89%

EV / EBITDA (TTM)967.00x

EPS Incl Extra (Annual)$1.56

Current Ratio (Annual)2.17x

Quick Ratio (Quarterly)1.96x

3-Month Avg Trading Volume0.67M

52-Week Price Return57.24%

P/E Incl Extra (TTM)10.02x

Revenue / Employee (TTM)$272,600

Tangible BV / Share (Quarterly)$7.00

P/S Ratio (Annual)4.84x

Asset Turnover (Annual)0.23x

52-Week High$18.36

Operating Margin (5Y Avg)-48.26%

EPS Excl Extra (Annual)$1.56

CapEx CAGR (5Y)15.07%

Tangible BV CAGR (5Y)16.65%

26-Week Price Return69.25%

Quick Ratio (Annual)2.03x

13-Week Price Return2.00%

Total Debt / Equity (Annual)0.37x

Current Ratio (Quarterly)2.08x

Enterprise Value$771.67M

Revenue / Share Growth (5Y)11.53%

Asset Turnover (TTM)0.24x

Book Value / Share Growth (5Y)0.95%

Revenue / Employee (Annual)$257,600

Inventory Turnover (Annual)4.08x

Pretax Margin (Annual)-18.26%

Cash / Share (Annual)$8.25

3-Month Return Std Dev36.98%

Gross Margin (5Y Avg)39.42%

Net Income / Employee (TTM)$-54,700

ROE (Last FY)15.58%

Net Interest Coverage (Annual)-16.12x

EPS Basic Excl Extra (Annual)$1.56

Receivables Turnover (TTM)5.34x

Total Debt / Equity (Quarterly)0.38x

EPS Incl Extra (TTM)$-0.75

Receivables Turnover (Annual)4.45x

ROI (TTM)-5.43%

P/S Ratio (TTM)4.57x

Pretax Margin (5Y Avg)-47.57%

Revenue / Share (Annual)$3.52

Tangible BV / Share (Annual)$7.31

Forward P/E6.12x

Price vs S&P 500 (52W)41.70%

P/E Ratio (TTM)10.02x

Year-to-Date Return75.42%

5-Day Price Return0.00%

EPS Normalized (Annual)$1.56

ROA (5Y Avg)-8.96%

Net Profit Margin (Annual)44.44%

Month-to-Date Return-3.22%

Cash Flow / Share (TTM)$-0.59

EBITD / Share (Annual)$-0.18

Operating Margin (Annual)-20.89%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)106.98x

ROI (5Y Avg)-9.86%

P/E Excl Extra (TTM)10.02x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.75

P/TBV (Quarterly)2.23x

P/B Ratio (Annual)0.96x

Inventory Turnover (TTM)4.43x

Pretax Margin (TTM)-16.63%

Book Value / Share (Annual)$10.08

Price vs S&P 500 (13W)-0.69%

Beta1.88x

Revenue / Share (TTM)$3.70

ROE (TTM)-7.47%

52-Week Low$7.61

vGradeC

gGradeC

mGradeA

vgmGradeC

CYRX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.18	-$0.20	-9.09%(-$0.02)
Q1 2026	May 4, 2026	-$0.19	-$0.19	+1.82%(+$0.00)
Q4 2025	Mar 3, 2026	-$0.21	-$0.17	+17.58%(+$0.04)
Q3 2025	Nov 4, 2025	-$0.19	-$0.13	+31.73%(+$0.06)
Q2 2025	Aug 5, 2025	-$0.22	-$0.24	-10.46%(-$0.02)

CYRX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.25

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
CYRXCryoPort, Inc. Common Stock	C	C	A	4.6x	-8.0%	47.1%	—	$16.84
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About CryoPort, Inc. Common Stock

Cryoport is a provider of integrated temperature-controlled logistics and products for the life sciences industry, serving biopharmaceutical, pharmaceutical, animal health, and reproductive medicine markets. The company operates two business segments: Life Sciences Services and Life Sciences Products. With global operations across the Americas, Europe, the Middle East, Africa, and Asia Pacific, Cryoport generates the majority of its revenue from North American operations.

CYRX Next Earnings Report

Report dateNov 3, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.17

Revenue estimate$48.69M

Also reporting on Nov 3, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

CYRX Insider Transactions

SellAug 11, 2026
SHELTON JERRELL WILSON
Chief Executive Officer
Shares: 28,800Value: $429,385

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

FMCFMC CorporationChemicals
FTKFlotek Industries, Inc.Industrial Chemicals
SLBTSL Science Holding Limited Ordinary SharesBiological Products
KROKronos Worldwide, Inc.Industrial Chemicals
CGEMCullinan Therapeutics, Inc. Common StockBiological Products
GLUEMonte Rosa Therapeutics, Inc. Common StockBiological Products
ODTXOdyssey Therapeutics, Inc. Common StockBiological Products
LXULSB INDUSTRIES INCIndustrial Chemicals

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.3

Strong Buy

Consensus rating

52-Week Range

Low$7.61

High$18.36